SENEXON-S- docusate sodium 50mg and sennosides 8.6mg tablet, film coated
NCS HealthCare of KY, LLC dba Vangard Labs
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
age |
starting dosage |
maximum dosage |
adults and children 12 years and over |
2 tablets once a day |
4 tablets twice a day |
children 6 to under 12 years |
1 tablet once a day |
2 tablets twice a day |
children 2 to under 6 years |
1/2 tablet once a day |
1 tablet twice a day |
children under 2 years |
ask a doctor |
ask a doctor |
croscarmellose sodium, D&C Yellow# 10, dicalcium phosphate, FD&C Yellow #6, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium benzoate, talc, titanium dioxide
SENEXON-S
docusate sodium 50mg and sennosides 8.6mg tablet, film coated |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Labeler - NCS HealthCare of KY, LLC dba Vangard Labs (050052943) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
NCS HealthCare of KY, LLC dba Vangard Labs | 050052943 | repack(0615-8331) |